Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Miller

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Oncology|September 24, 2015
Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource CountriesLinus Chuang, Margaux J Kanis, Brigitte Miller, et al.
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|June 7, 2017
Problems Experienced by Ovarian Cancer Survivors During TreatmentJessica Keim-Malpass, Shannon L Mihalko, Greg Russell, et al.
Pediatric Blood & Cancer|July 22, 2004
Adenocarcinoma of the cervix and vagina in pediatric patientsRené Y McNall, Philip D Nowicki, Brigitte Miller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancerMichael Friedlander, Phyllis Butow, Martin Stockler, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418Anuja Jhingran, Kathryn Winter, Lorraine Portelance, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128David K Gaffney, Kathryn Winter, Adam P Dicker, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2007
Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128David K Gaffney, Kathryn Winter, Adam P Dicker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128Akila N Viswanathan, Jennifer Moughan, William Small, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 5, 2010
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registryCyril William Helm, Scott D Richard, Jianmin Pan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Clinical trials in recurrent ovarian cancerMichael Friedlander, Edward Trimble, Anna Tinker, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Oncology|September 24, 2015
Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource CountriesLinus Chuang, Margaux J Kanis, Brigitte Miller, et al.
Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN|June 7, 2017
Problems Experienced by Ovarian Cancer Survivors During TreatmentJessica Keim-Malpass, Shannon L Mihalko, Greg Russell, et al.
Pediatric Blood & Cancer|July 22, 2004
Adenocarcinoma of the cervix and vagina in pediatric patientsRené Y McNall, Philip D Nowicki, Brigitte Miller, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 4, 2009
Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancerMichael Friedlander, Phyllis Butow, Martin Stockler, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418Anuja Jhingran, Kathryn Winter, Lorraine Portelance, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2006
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128David K Gaffney, Kathryn Winter, Adam P Dicker, et al.
International Journal of Radiation Oncology, Biology, Physics|May 8, 2007
Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128David K Gaffney, Kathryn Winter, Adam P Dicker, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 24, 2011
The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128Akila N Viswanathan, Jennifer Moughan, William Small, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 5, 2010
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registryCyril William Helm, Scott D Richard, Jianmin Pan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Clinical trials in recurrent ovarian cancerMichael Friedlander, Edward Trimble, Anna Tinker, et al.
Pageof 1